Genetic Basis for Adverse Events After Smallpox Vaccination

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2008 May 6

PMID 18454680

Citations 45

Authors

David M Reif

Brett A McKinney

Alison A Motsinger

Stephen J Chanock

Kathryn M Edwards

Michael T Rock

Jason H Moore

James E Crowe

Affiliations

Soon will be listed here.

Abstract

Identifying genetic factors associated with the development of adverse events might allow screening before vaccinia virus administration. Two independent clinical trials of the smallpox vaccine (Aventis Pasteur) were conducted in healthy, vaccinia virus-naive adult volunteers. Volunteers were assessed repeatedly for local and systemic adverse events (AEs) associated with the receipt of vaccine and underwent genotyping for 1,442 singlenucleotide polymorphisms (SNPs). In the first study, 36 SNPs in 26 genes were associated with systemic AEs (P <or= .05); these 26 genes were tested in the second study. In the final analysis, 3 SNPs were consistently associated with AEs in both studies. The presence of a nonsynonymous SNP in the methylenetetrahydrofolate reductase (MTHFR)gene was associated with the risk ofAEin both trials (odds ratio [OR], 2.3 [95% confidence interval {CI}, 1.1-5.2] [P = .04] and OR, 4.1 [95% CI, 1.4 -11.4] [P<.01]). Two SNPs in the interferon regulatory factor-1 (IRF1) gene were associated with the risk of AE in both sample sets (OR, 3.2 [95% CI, 1.1-9.8] [P = .03] andOR, 3.0 [95% CI, 1.1- 8.3] [P = .03]). Genetic polymorphisms in genes expressing an enzyme previously associated with adverse reactions to a variety of pharmacologic agents (MTHFR) and an immunological transcription factor (IRF1) were associated with AEs after smallpox vaccination in 2 independent study samples.

Citing Articles

Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines.

Bellavite P, Ferraresi A, Isidoro C Biomedicines. 2023; 11(2).

PMID: 36830987 PMC: 9953067. DOI: 10.3390/biomedicines11020451.

Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics.

Ferraresi A, Isidoro C Biomedicines. 2023; 11(1).

PMID: 36672560 PMC: 9855897. DOI: 10.3390/biomedicines11010052.

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents.

Smatti M, AlKhatib H, Al Thani A, Yassine H Front Med (Lausanne). 2022; 9:802312.

PMID: 35360730 PMC: 8962369. DOI: 10.3389/fmed.2022.802312.

Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects.

Liu R, Americo J, Earl P, Villani J, Cotter C, Moss B mBio. 2022; 13(1):e0010222.

PMID: 35189701 PMC: 8903894. DOI: 10.1128/mbio.00102-22.

Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain.

Eto A, Yamamoto N, Kanatani Y Biology (Basel). 2021; 10(11).

PMID: 34827150 PMC: 8614788. DOI: 10.3390/biology10111158.

References

Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A . Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 1989; 58(4):729-39. DOI: 10.1016/0092-8674(89)90107-4. View

Lake S, Lyon H, Tantisira K, Silverman E, Weiss S, Laird N . Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003; 55(1):56-65. DOI: 10.1159/000071811. View

Stanley Jr S, Frey S, Taillon-Miller P, Guo J, Miller R, Koboldt D . The immunogenetics of smallpox vaccination. J Infect Dis. 2007; 196(2):212-9. DOI: 10.1086/518794. View

Grom A, Passo M . Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediatr. 1996; 129(5):630-2. DOI: 10.1016/s0022-3476(96)70140-3. View

Shaklee J, Talbot T, Muldowney 3rd J, Vaughan D, Butler J, House F . Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. J Infect Dis. 2005; 191(5):724-30. DOI: 10.1086/427831. View

Kemper A, Davis M, Freed G . Expected adverse events in a mass smallpox vaccination campaign. Eff Clin Pract. 2002; 5(2):84-90. View

McKinney B, Reif D, Rock M, Edwards K, Kingsmore S, Moore J . Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis. 2006; 194(4):444-53. PMC: 1620015. DOI: 10.1086/505503. View

Rock M, Yoder S, Talbot T, Edwards K, Crowe Jr J . Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis. 2004; 189(8):1401-10. DOI: 10.1086/382510. View

Rock M, Yoder S, Talbot T, Edwards K, Crowe Jr J . Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine. J Infect Dis. 2006; 194(4):435-43. DOI: 10.1086/505506. View

10.

van den Broek M, Muller U, Huang S, Aguet M, Zinkernagel R . Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol. 1995; 69(8):4792-6. PMC: 189290. DOI: 10.1128/JVI.69.8.4792-4796.1995. View

11.

Symons J, Alcami A, Smith G . Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 1995; 81(4):551-60. DOI: 10.1016/0092-8674(95)90076-4. View

12.

Lim U, Peng K, Shane B, Stover P, Litonjua A, Weiss S . Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr. 2005; 135(8):1989-94. DOI: 10.1093/jn/135.8.1989. View

13.

Jackson R, Ramsay A, Christensen C, Beaton S, HALL D, Ramshaw I . Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol. 2001; 75(3):1205-10. PMC: 114026. DOI: 10.1128/JVI.75.3.1205-1210.2001. View

14.

Hirschhorn J, Lohmueller K, Byrne E, Hirschhorn K . A comprehensive review of genetic association studies. Genet Med. 2002; 4(2):45-61. DOI: 10.1097/00125817-200203000-00002. View

15.

Howell M, Gallo R, Boguniewicz M, Jones J, Wong C, Streib J . Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006; 24(3):341-8. DOI: 10.1016/j.immuni.2006.02.006. View

16.

Garcia-Closas M, Malats N, Real F, Yeager M, Welch R, Silverman D . Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet. 2007; 3(2):e29. PMC: 1802828. DOI: 10.1371/journal.pgen.0030029. View

17.

Crawford D, Nickerson D . Definition and clinical importance of haplotypes. Annu Rev Med. 2005; 56:303-20. DOI: 10.1146/annurev.med.56.082103.104540. View

18.

Talbot T, Bredenberg H, Smith M, LaFleur B, Boyd A, Edwards K . Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA. 2003; 289(24):3290-4. DOI: 10.1001/jama.289.24.3290. View

19.

Alcami A, Symons J, Smith G . The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol. 2000; 74(23):11230-9. PMC: 113220. DOI: 10.1128/jvi.74.23.11230-11239.2000. View

20.

Dedoussis G, Panagiotakos D, Pitsavos C, Chrysohoou C, Skoumas J, Choumerianou D . An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease. Int J Cardiol. 2005; 100(3):409-14. DOI: 10.1016/j.ijcard.2004.08.038. View